Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can the response to mood stabilizers be predicted in bipolar disorder?

Frontiers in bioscience (Elite edition) - 1 Jan 2014

Geoffroy Pierre Alexis, Bellivier Frank, Leboyer Marion, Etain Bruno

Abstract excerpt

Bipolar disorder (BD) is a severe chronic multifactorial disease that requires maintenance therapy with mood stabilizers (MS). Even with medications, the rate of response among patients with BD is low and the risk of relapse is high. Therefore, in this context of the urgent need for reliable and reproducible predictors of individual responses to MS, pharmacogenetics research is expected to provide helpful...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimanic Agents
Share to Bipolar Disorder
Share to Circadian Rhythm Signaling Peptides and Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inositol

Share to Lithium

Share to Neurotransmitter Agents

Share to Pharmacogenetics

Share to Valproic Acid

Source

Identifiers

PMID: 24389147
DOI: 10.2741/e696

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can the response to mood stabilizers be predicted in bipolar disorder?PMID 24389147Read ↗

Genetics and Antiepileptic Mood Stabilizer Treatment Response in Bipolar Disorder: What do we Know?Semantic proximity Read ↗

Pharmacogenomics of Bipolar DisorderSemantic proximity Read ↗

Pharmacogenomic aspects of bipolar disorder: An updateSemantic proximity Read ↗

Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium study.Semantic proximity Read ↗

Response to Lithium in Bipolar Disorder: Clinical and Genetic FindingsSemantic proximity Read ↗

Pharmacogenetics of lithium response in bipolar disorder.Semantic proximity Read ↗

Lithium Pharmacogenetics: Where Do We Stand?Semantic proximity Read ↗

Response to treatment in bipolar disorder.Semantic proximity Read ↗

Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression.Semantic proximity Read ↗

Exploring the genetics of lithium response in bipolar disordersSemantic proximity Read ↗

Mood-Stabilizing Antiepileptic Treatment Response in Bipolar Disorder: A Genome-Wide Association Study.Semantic proximity Read ↗

Recent Trends on the Role of Epigenomics, Metabolomics and Noncoding RNAs in Rationalizing Mood Stabilizing TreatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.